Johnson & Johnson Family of Companies
NEWS
The company has agreed to deliver 100 million doses of the vaccines by the end of June.
The date set by the FDA’s independent advisors for debating that decision is Friday, February 26.
There’s plenty of COVID-19-related news today. Here’s a look.
It was a busy week for clinical trial announcements and news. Here’s a look.
South Africa recently announced it was halting distribution of the AstraZeneca-University of Oxford COVID-19 vaccine after data suggested it “provides minimal protection” against mild disease from the South African variant.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for February 9, 2021.
Johnson & Johnson’s Janssen Biotech submitted an application to the U.S. Food and Drug Administration (FDA) for emergency use authorization (EUA) for its single-dose COVID-19 vaccine.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for February 2, 2021.
Overall, against moderate-severe COVID-19 infection, the vaccine was 72% effective 28 days after vaccination in the U.S., 66% in hard-hit Latin America, and bottomed out at 57% in South Africa.
JOBS
IN THE PRESS